However, in order to explore the potential application of HSP90 inhibitors in RCC, we first need to clarify the expression characteristics and regulatory mechanisms of other members of the HSP90 family in RCC, and determine whether they play a role in tumor suppression or promotion. Here, HSP90AB1 is linked to renal cell carcinoma.